Copaxone gains expanded indication - MPR
Links shared publicly online about this topic.
- 2,216total visits
Copaxone gains expanded indication - MPR
empr.com —
View full resource at empr.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Imaging Tests, Magnetic Resonance Imaging, FDA, Copaxone
Most Recently Shared on March 3, 2009 at 9:23 pm By:
Copaxone gains expanded indication: The FDA has approved an expanded indication for Copaxone (glatiramer acetate.. http://tinyurl.com/agh5sm
Menactra Gains Indication for Immunization of Infants - ONA
oncologynurseadvisor.com — “The FDA has expanded the indication for Menactra (meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine; Sanofi Pasteur) to include a two-dose schedule for infants and children 9--23 months old.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 25, 2011 at 7:05 pm By:
Menactra Gains Indication for Immunization of Infants http://goo.gl/fb/9NRz4
Angioplasty, angiography, radial artery: Alternative angioplasty route gains favor - Health Key
healthkey.com — “Performing angioplasty and angiography through the radial artery of the arm is found to be as effective as the usual way, through the femoral artery of the leg, a study shows. But the radial route has fewer complications and is more comfortable for the patient, indicating its usage will expand.” View full resource at healthkey.com
Most Recently Shared on April 5, 2011 at 3:45 am By:
Abstract Presentation: Alternative angioplasty route gains favor (ACC Meeting) http://bit.ly/fzFp2F - #health
Angioplasty, angiography, radial artery: Alternative angioplasty route gains favor - latimes.com
latimes.com — “Performing angioplasty and angiography through the radial artery of the arm is found to be as effective as the usual way, through the femoral artery of the leg, a study shows. But the radial route has fewer complications and is more comfortable for the patient, indicating its usage will expand.” View full resource at latimes.com
Most Recently Shared on April 5, 2011 at 12:10 am By:
Zostavax Gains Expanded Indication - ONA
oncologynurseadvisor.com — “Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50--59 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 25, 2011 at 3:07 pm By:
Infergen gains expanded indication - ONA
oncologynurseadvisor.com — “The FDA has approved expanded labeling for Infergen (consensus interferon, from Three Rivers) to include its daily use in combination with ribavirin for retreatment of chronic hepatitis C patients.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 6, 2010 at 3:53 pm By:
Biogen's Rituxan Label Expansion Delayed
zacks.com — “Biogen's rituxan label expansion delayed-biogen works towards gaining final approval for the expanded indication and are planning to continue final label discussions with the fda” View full resource at zacks.com
Most Recently Shared on November 20, 2009 at 5:09 pm By:
Rituxan shot down as part of first-line therapy for CLL http://bit.ly/8LKlRa
Advertisement

